Thoratec Corporation (THOR) - Product Pipeline Analysis, 2015 Update

Date: March 26, 2015
Pages: 45
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T5CDFC17843EN
Leaflet:

Download PDF Leaflet

Thoratec Corporation (THOR) - Product Pipeline Analysis, 2015 Update
Summary

Thoratec Corporation (Thoratec) is a medical device company. It undertakes the research, development, manufacture and marketing of proprietary medical devices used for mechanical circulatory support for the treatment of heart failure (HF) patients. The major product of the company includes Thoratec Paracorporeal Ventricular Assist DeviceThoratec Implantable Ventricular Assist DeviceHeartMate Left Ventricular Assist Systemand HeartMate II Left Ventricular Assist System. The company also offers acute circulatory support products including CentriMag acute circulatory system and PediMag/PediVAS pediatric acute circulatory system. Thoratec’s products are marketed and sold in the US, Europe, Japan and other countries. The company markets its products to heart transplant hospitals and large cardiac surgery centers. Thoratec is headquartered in California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Thoratec Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

    Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
  • Thoratec Corporation Company Snapshot
    Thoratec Corporation Company Overview
    Key Information
    Thoratec Corporation Pipeline Products and Clinical Trials Overview
    Thoratec Corporation – Pipeline Analysis Overview
    Business Description
    Key Facts
    Thoratec Corporation - Major Products and Services
    Thoratec Corporation Pipeline Products by Development Stage
    Thoratec Corporation Clinical Trials by Trial Status
    Thoratec Corporation Pipeline Products Overview
    Apica VAD SIS Device
    Apica VAD SIS Device Product Overview
    Apical Access System
    Apical Access System Product Overview
    Automated Anastomosis Device
    Automated Anastomosis Device Product Overview
    Fully Implantable Ventricular Assist System
    Fully Implantable Ventricular Assist System Product Overview
    HeartMate III LVAS - Bridge-to-Transplant
    HeartMate III LVAS - Bridge-to-Transplant Product Overview
    HeartMate III LVAS - Bridge-to-Transplant Clinical Trial
    HeartMate III LVAS - Destination Therapy
    HeartMate III LVAS - Destination Therapy Product Overview
    HeartMate III LVAS - Destination Therapy Clinical Trial
    HeartMate Percutaneous Heart Pump
    HeartMate Percutaneous Heart Pump Product Overview
    HeartMate Percutaneous Heart Pump Clinical Trial
    HeartMate X
    HeartMate X Product Overview
    Next Generation Device For TAVI
    Next Generation Device For TAVI Product Overview
    Remote Monitoring Device
    Remote Monitoring Device Product Overview
    UltraMag Adult Ventricular Assist System
    UltraMag Adult Ventricular Assist System Product Overview
    UltraMag Pediatric Ventricular Assist System
    UltraMag Pediatric Ventricular Assist System Product Overview
    Universal Port Access System
    Universal Port Access System Product Overview
    Thoratec Corporation - Key Competitors
    Thoratec Corporation - Key Employees
    Thoratec Corporation - Key Employee Biographies
    Thoratec Corporation - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Recent Developments
    Thoratec Corporation, Recent Developments
    Feb 10, 2015: Thoratec Reports Fourth Quarter 2014 Results
    Dec 01, 2014: Thoratec Announces Completion Of Enrollment In The HeartMate III CE Mark Trial
    Nov 05, 2014: Thoratec Reports Third Quarter 2014 Results
    Oct 06, 2014: Thoratec Announces Additions To Senior Management Team
    Sep 22, 2014: Thoratec Appoints D. Keith Grossman President And Chief Executive Officer
    Sep 09, 2014: Thoratec Announces Start Of Heartmate III U.S. Clinical Trial
    Aug 06, 2014: Thoratec Reports Second Quarter 2014 Results
    Aug 06, 2014: Thoratec Announces Start Of The HeartMate PHP CE Mark Trial
    Jun 27, 2014: Thoratec Announces First HeartMate III Human Implant And Start Of CE Mark Trial
    May 06, 2014: Thoratec Reports First Quarter 2014 Results
    Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Thoratec Corporation, Key Facts
    Thoratec Corporation Pipeline Products and Clinical Trials Overview
    Thoratec Corporation Pipeline Products by Equipment Type
    Thoratec Corporation Pipeline Products by Indication
    Thoratec Corporation Clinical Trials by Trial Status
    Thoratec Corporation, Key Facts
    Thoratec Corporation, Major Products and Services
    Thoratec Corporation Number of Pipeline Products by Development Stage
    Thoratec Corporation Pipeline Products Summary by Development Stage
    Thoratec Corporation Clinical Trials by Trial Status
    Thoratec Corporation Clinical Trials Summary
    Apica VAD SIS Device - Product Status
    Apica VAD SIS Device - Product Description
    Apical Access System - Product Status
    Apical Access System - Product Description
    Automated Anastomosis Device - Product Status
    Automated Anastomosis Device - Product Description
    Fully Implantable Ventricular Assist System - Product Status
    Fully Implantable Ventricular Assist System - Product Description
    HeartMate III LVAS - Bridge-to-Transplant - Product Status
    HeartMate III LVAS - Bridge-to-Transplant - Product Description
    HeartMate III LVAS - Bridge-to-Transplant - Thoratec Corporation HeartMate III IDE Clinical Study Protocol
    HeartMate III LVAS - Destination Therapy - Product Status
    HeartMate III LVAS - Destination Therapy - Product Description
    HeartMate III LVAS - Destination Therapy - Thoratec Corporation Heartmate III CE Mark Clinical Investigation Plan
    HeartMate Percutaneous Heart Pump - Product Status
    HeartMate Percutaneous Heart Pump - Product Description
    HeartMate Percutaneous Heart Pump - HeartMate PHP CE Mark Clinical Investigation Plan
    HeartMate Percutaneous Heart Pump - Thoratec Corporation HeartMate PHP Cardiogenic Shock Trial
    HeartMate X - Product Status
    HeartMate X - Product Description
    Next Generation Device For TAVI - Product Status
    Next Generation Device For TAVI - Product Description
    Remote Monitoring Device - Product Status
    Remote Monitoring Device - Product Description
    UltraMag Adult Ventricular Assist System - Product Status
    UltraMag Adult Ventricular Assist System - Product Description
    UltraMag Pediatric Ventricular Assist System - Product Status
    UltraMag Pediatric Ventricular Assist System - Product Description
    Universal Port Access System - Product Status
    Universal Port Access System - Product Description
    Thoratec Corporation, Key Employees
    Thoratec Corporation, Key Employee Biographies
    Thoratec Corporation, Subsidiaries

    LIST OF FIGURES

    Thoratec Corporation Pipeline Products by Equipment Type
    Thoratec Corporation Pipeline Products by Development Stage
    Thoratec Corporation Clinical Trials by Trial Status
    Skip to top


    Ask Your Question

    Thoratec Corporation (THOR) - Product Pipeline Analysis, 2015 Update
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: